P

Inventor

PENG XIAOWEN

US63 patents
⚠️ This page may combine multiple inventors who share the name “PENG XIAOWEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ENANTA PHARM INC

31 patents
US10538532B2Jan 21, 2020

Hepatitis B antiviral agents

ENANTA PHARM INC17 citations94
US10428070B2Oct 1, 2019

Hepatitis B antiviral agents

ENANTA PHARM INC24 citations94
US10189846B2Jan 29, 2019

Hepatitis B antiviral agents

ENANTA PHARM INC25 citations94
US10179792B2Jan 15, 2019

Hepatitis B antiviral agents

ENANTA PHARM INC17 citations94
US10179131B2Jan 15, 2019

Hepatitis B antiviral agents

ENANTA PHARM INC27 citations94
US11596611B2Mar 7, 2023

Hepatitis B antiviral agents

ENANTA PHARM INC5 citations86
US11339170B1May 24, 2022

Spiropyrrolidine derived antiviral agents

ENANTA PHARM INC17 citations86
US10729688B2Aug 4, 2020

Hepatitis B antiviral agents

ENANTA PHARM INC11 citations86
US10723733B2Jul 28, 2020

Hepatitis B antiviral agents

ENANTA PHARM INC13 citations86
US10640511B2May 5, 2020

Hepatitis B antiviral agents

ENANTA PHARM INC13 citations86
US11319325B1May 3, 2022

Macrocyclic spiropyrrolidine derived antiviral agents

ENANTA PHARM INC14 citations85
US10952978B2Mar 23, 2021

Hepatitis B antiviral agents

ENANTA PHARM INC6 citations84
US10934306B2Mar 2, 2021

Hepatitis B antiviral agents

ENANTA PHARM INC5 citations84
US11912714B2Feb 27, 2024

Spiropyrrolidine derived antiviral agents

ENANTA PHARM INC6 citations75
US12011425B2Jun 18, 2024

Hepatitis B antiviral agents

ENANTA PHARM INC1 citations73
US10017499B2Jul 10, 2018

Benzimidazole derivatives

ENANTA PHARM INC2 citations73
US9676802B2Jun 13, 2017

Hepatitis C virus inhibitors

ENANTA PHARM INC6 citations73
US12496282B2Dec 16, 2025

Hepatitis B antiviral agents

ENANTA PHARM INC0 citations62
US12054493B2Aug 6, 2024

Hepatitis B antiviral agents

ENANTA PHARM INC0 citations62
US12398147B2Aug 26, 2025

Macrocyclic spiropyrrolidine derived antiviral agents

ENANTA PHARM INC0 citations52
US11976084B2May 7, 2024

Spiropyrrolidine derived antiviral agents

ENANTA PHARM INC0 citations52
US11970502B2Apr 30, 2024

Macrocyclic antiviral agents

ENANTA PHARM INC0 citations52
US11760755B2Sep 19, 2023

Hepatitis B antiviral agents

ENANTA PHARM INC0 citations52
US11472808B2Oct 18, 2022

Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents

ENANTA PHARM INC0 citations52
US11236111B2Feb 1, 2022

Hepatitis B antiviral agents

ENANTA PHARM INC0 citations52
US10752611B2Aug 25, 2020

Benzimidazole derivatives

ENANTA PHARM INC0 citations52
US10702528B2Jul 7, 2020

Hepatitis B antiviral agents

ENANTA PHARM INC0 citations52
US9000020B2Apr 7, 2015

Linked dibenzimidazole antivirals

ENANTA PHARM INC0 citations52
US8921573B2Dec 30, 2014

Processes for the preparation of novel benzimidazole derivatives

ENANTA PHARM INC2 citations52
US12540141B2Feb 3, 2026

Spiropyrrolidine derived antiviral agents

ENANTA PHARM INC0 citations51
US12479854B2Nov 25, 2025

Spiropyrrolidine derived antiviral agents

ENANTA PHARM INC0 citations51

QIU YAO-LING

12 patents

OR YAT SUN

7 patents

Showing the top 50 of 63 patents by PatentIndex Score.